To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about ...
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...
1d
Zacks.com on MSNShould You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?Given the uncertainty around its revenue growth, we advise short-term investors to remain cautious when investing in MRNA ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...
Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
Bird flu has now spread to humans in a dozen states after public health officials confirmed an Ohio man had contracted the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results